What is the appropriate testing protocol for suspected celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Testing for Celiac Disease

Start with IgA tissue transglutaminase antibody (TG2-IgA) testing combined with total serum IgA measurement as your initial screening approach 1, 2.

Initial Serological Testing Algorithm

The diagnostic pathway begins with two blood tests performed simultaneously:

  • TG2-IgA: This is the single best serologic test for celiac disease detection 1, 3
  • Total serum IgA: Essential to identify IgA deficiency, which occurs in approximately 2-3% of celiac patients and causes false-negative IgA-based tests 1

If total IgA is low or undetectable, switch to IgG-based testing: order IgG tissue transglutaminase (TG2-IgG) or IgG deamidated gliadin peptide antibodies 1, 4. Do not use IgG testing if IgA levels are normal, as TG2-IgG lacks specificity in IgA-sufficient patients 1.

Interpreting Positive Results

Strongly Positive TG2-IgA (≥10× Upper Limit of Normal)

In adults with TG2-IgA levels ≥10× ULN, you can conditionally make a diagnosis without biopsy if you confirm with positive IgA endomysial antibodies (EMA-IgA) in a second blood sample 2. When both tests are positive at these levels, the positive predictive value approaches 100% 1. However, esophagogastroduodenoscopy (EGD) with biopsies should still be performed for differential diagnosis purposes 1.

Weakly Positive TG2-IgA (<10× ULN)

Proceed directly to EGD with duodenal biopsies 1, 2. The biopsy protocol matters significantly for diagnostic accuracy:

  • Obtain at least 4 biopsies from the second portion of the duodenum (distal duodenum)
  • Add at least 1-2 biopsies from the duodenal bulb at the 9 o'clock and 12 o'clock positions 5, 3
  • Request thorough histological analysis with Marsh classification and lymphocyte counting 1

This multi-site biopsy approach maximizes sensitivity, as celiac changes can be patchy and may be more prominent in the bulb in some patients.

Critical Pitfalls to Avoid

The Gluten-Free Diet Problem

Never allow patients to start a gluten-free diet before completing diagnostic testing 1. Gluten avoidance reduces sensitivity of both serology and biopsy, leading to false-negatives and diagnostic uncertainty.

If a patient has already started avoiding gluten:

  • Have them resume a normal diet with three slices of wheat bread daily for 1-3 months before repeating TG2-IgA testing 1
  • This gluten challenge is necessary to unmask the disease

When Serology and Biopsy Disagree

If TG2-IgA is positive but biopsies show no or minimal changes (Marsh 0/I), the patient still has confirmed autoimmunity and requires close follow-up 5. Consider repeat biopsies if clinical suspicion remains high 1, 6.

Conversely, if biopsies show villous atrophy but serology is negative, perform celiac-specific serology as confirmatory testing and consider HLA-DQ2/DQ8 typing to help clarify the diagnosis 1.

Role of HLA Testing

HLA-DQ2/DQ8 genetic testing has limited diagnostic utility but high negative predictive value 1, 2. Use it selectively in these scenarios:

  • Patients with seronegative villous atrophy requiring diagnostic clarification
  • Patients already on a gluten-free diet who lack prior serologic confirmation (negative HLA rules out celiac disease, avoiding need for gluten challenge) 3
  • Patients with historic childhood diagnosis before modern serology was available 1

Do not use HLA testing as a routine screening tool—its value lies in ruling out rather than ruling in celiac disease.

Tests NOT Recommended

Do not use IgG/IgA deamidated gliadin peptide antibodies (DGP) for initial testing 1. While these have some utility in IgA deficiency, TG2-IgA combined with total IgA measurement is superior for the initial diagnostic approach.

Do not routinely order IgA endomysial antibodies (EMA-IgA) as your first test 1, 2. Reserve EMA-IgA for confirmation in cases with very high TG2-IgA levels when considering a no-biopsy diagnosis, as it adds specificity 1.

Special Populations Requiring Screening

Even without symptoms, actively screen these high-risk groups 7:

  • First-degree relatives of celiac patients
  • Type 1 diabetes mellitus
  • Autoimmune thyroid disease (Hashimoto's, Graves')
  • Down syndrome, Turner syndrome, Williams syndrome
  • Unexplained iron deficiency anemia
  • Unexplained elevation of liver enzymes
  • Autoimmune hepatitis or primary biliary cholangitis
  • Premature osteoporosis
  • IgA deficiency

The most recent evidence from 2024-2025 guidelines emphasizes that case-finding in these populations is more effective than mass screening for identifying undiagnosed celiac disease 2, 7.

References

3
Research

Celiac Disease: Ten Things That Every Gastroenterologist Should Know.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015

Related Questions

When and how should I screen for celiac disease?
How do you work up a patient for celiac disease or Crohn disease?
What are the recommended investigations and treatment for celiac disease?
Can left lower quadrant abdominal pain, constipation, diarrhea, and bloating be manifestations of celiac disease?
What is the most appropriate initial test to screen for celiac disease in a 20‑year‑old patient who experiences bloating after consuming gluten‑containing foods?
Is it correct that ultra‑rapid metabolizers require higher drug doses while poor metabolizers have roughly double the risk of adverse events, that CYP2C19 loss‑of‑function alleles (e.g., *2) double the risk of cardiovascular events with clopidogrel, and that CYP2D6 polymorphisms diminish the analgesic effect of codeine, tramadol, and oxycodone in poor metabolizers and cause potentially lethal toxicity in ultra‑rapid metabolizers?
In an adult with lifelong idiopathic nightmares not linked to any specific cause, would prazosin be effective, or are night terrors a distinct condition requiring different treatment?
Explain how the hippocampus contributes to memory formation, working memory, and long‑term storage.
In a 21-year-old woman who had a recent termination and is experiencing ongoing vaginal bleeding while using a contraceptive implant, with low ferritin, low transferrin saturation, and normal hemoglobin, how should the iron deficiency and persistent bleeding be managed?
How should a patient with a procalcitonin level of 1 ng/mL be managed?
At what dose of trazodone do adverse effects begin to be reported?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.